• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    James River Completes Closing of Adverse Development Cover and Common Equity Investment with Cavello Bay Reinsurance Limited

    12/23/24 4:05:00 PM ET
    $JRVR
    Property-Casualty Insurers
    Finance
    Get the next $JRVR alert in real time by email

    PEMBROKE, Bermuda, Dec. 23, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ:JRVR) today announced the close of both the adverse development reinsurance agreement and $12.5 million common equity investment with Enstar subsidiary Cavello Bay Reinsurance Limited, as per the terms and agreements previously announced on November 11, 2024.

    About James River Group Holdings, Ltd.

    James River Group Holdings, Ltd. is a Bermuda-based insurance holding company that owns and operates a group of specialty insurance companies. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance. Each of the Company's regulated insurance subsidiaries are rated "A-" (Excellent) by A.M. Best Company.

    Visit James River Group Holdings, Ltd. on the web at www.jrvrgroup.com.



    For more information contact:
    
    Zachary Shytle
    Senior Analyst, Investments and Investor Relations
    980-249-6848
    [email protected]

    Primary Logo

    Get the next $JRVR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JRVR

    DatePrice TargetRatingAnalyst
    3/22/2024$12.00Neutral → Buy
    Compass Point
    11/9/2023$32.00 → $15.00Buy → Hold
    Truist
    11/9/2023$22.00 → $14.00Outperform → Mkt Perform
    Keefe Bruyette
    11/9/2023$15.00 → $12.00Equal Weight → Underweight
    Barclays
    11/2/2022Buy → Neutral
    Compass Point
    3/4/2022$42.00 → $31.00Buy
    B. Riley Securities
    3/1/2022$45.00 → $36.00Market Outperform
    JMP Securities
    1/6/2022$32.00 → $29.00Equal-Weight
    Barclays
    More analyst ratings